MENU
+Compare
RLMD
Stock ticker: NASDAQ
AS OF
Aug 11, 10:45 AM (EDT)
Price
$0.58
Change
-$0.01 (-1.69%)
Capitalization
19.5M

RLMD Relmada Therapeutics Chart, History Price & Graph

a clinical-stage biotechnology company, which engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases

RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RLMD showed earnings on August 07, 2025. You can read more about the earnings report here.
View a ticker or compare two or three
RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement

RLMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with ENTO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then ENTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
-2.41%
ENTO - RLMD
35%
Loosely correlated
-6.20%
ARGNF - RLMD
31%
Poorly correlated
N/A
PLUR - RLMD
27%
Poorly correlated
-0.29%
TPST - RLMD
26%
Poorly correlated
+4.69%
PPBT - RLMD
26%
Poorly correlated
-0.93%
More